Abstract
Elastic vesicles have been developed and evaluated as novel topical and transdermal delivery systems. They are similar to conventional liposomes but with the incorporation of an edge activator in the lipid bilayer structure to provide elasticity. Elastic vesicles are applied non-occluded to the skin and have been shown to permeate through the stratum corneum lipid lamellar regions as a result of the hydration or osmotic force in the skin. They have been investigated as drug carriers for a range of small molecules, peptides, proteins and vaccines, both in vitro and in vivo. Following topical application, structural changes in the stratum corneum have been identified and intact elastic vesicles visualised within the stratum corneum lipid lamellar regions, but no intact vesicles have been identified in the deeper viable tissues. Their method of transporting their drug payload into and through the skin has been investigated but remains an area of contention. This chapter provides an overview of the development of elastic vesicles for delivery into and via the skin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ainbinder D, Touitou E (2005) Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv 12(5):297–303
Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA (2010) Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J Control Release 148(3):266–282
Bangham AD (1963) Physical structure and behavior of lipids and lipid enzymes. Adv Lipid Res 1:65–104
Blume G, Pitterman W, Waldmann-Laue M, Kietzmann M, Verma DD, Johan C (2000) Rovisome-a carrier system for vitamins. Euro Cosmetics 3:30–32
Boinpally RR, Zhou SL, Poondru S, Devraj G, Jasti BR (2003) Lecithin vesicles for topical delivery of diclofenac. Eur J Pharm Biopharm 56(3):389–392
Bouwstra JA, De Graaff A, Groenink W, Honeywell L (2002) Elastic vesicles: interaction with human skin and drug transport. Cell Mol Biol Lett 7(2):222–223
Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M (2003) Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42(1):1–36
Carafa M, Santucci E, Lucania G (2002) Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm 231(1):21–32
Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13(3–4):257–388
Cevc G (2003) Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 42(5):461–474
Cevc G (2012) Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy. J Control Release 160(2):135–146
Cevc G, Blume G (1992) Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104(1):226–232
Cevc G, Blume G (2001) New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 1514(2):191–205
Cevc G, Schatzlein A, Blume G (1995) Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Release 36:3–16
Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368(2):201–215
Cevc G, Schatzlein A, Richardsen H (2002) Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 1564(1):21–30
Cosco D, Celia C, Cilurzo F, Trapasso E, Paolino D (2008) Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv 5(7):737–755
Dayan N, Touitou E (2000) Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21(18):1879–1885
Ding Z, Bal SM, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA (2011) Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array. Pharm Res 28(1):145–158
Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A (2008) Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release 127(1):59–69
Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK (2007) Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 123(2):148–154
El Maghraby GM, Williams AC, Barry BW (1999) Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51(10):1123–1134
El Maghraby GM, Williams AC, Barry BW (2004) Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 276(1–2):143–161
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2006) Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 322(1–2):60–66
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2007) Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332(1–2):1–16
Geusens B, Van Gele M, Braat S, De Smedt SC, Stuart MC, Prow TW, Sanchez W, Roberts MS, Sanders N, Lambert J (2010) “Flexible Nanosomes (SECosomes) Enable Efficient siRNA Delivery in Cultured Primary Skin Cells and in the Viable Epidermis of Ex Vivo Human Skin.” Adv Funct Mater 20(23):4077–4090
Godin B, Touitou E (2003) Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 20(1):63–102
Guo J, Ping Q, Zhang L (2000a) Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv 7(2):113–116
Guo J, Ping Q, Sun G, Jiao C (2000b) Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm 194(2):201–207
Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y (2013) Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharm 447(1–2):22–30
Gupta PN, Mishra V, Rawat A, Dubey P, Mahor S, Jain S, Chatterji DP, Vyas SP (2005a) Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 293(1–2):73–82
Gupta PN, Mishra V, Singh P, Rawat A, Dubey P, Mahor S, Vyas SP (2005b) Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol 57(3):295–301
Hirschberg H, van Kuijk S, Loch J, Jiskoot W, Bouwstra J, Kersten G, Amorij JP (2012) A combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis B virus. Eur J Pharm Sci 46(1–2):1–7
Hofland HE, Bouwstra JA, Bodde HE, Spies F, Junginger HE (1995) Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br J Dermatol 132(6):853–866
Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2(1):67–74
Honeywell-Nguyen PL, de Graaff AM, Wouter Groenink HW, Bouwstra JA (2002) The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta 1573(2):130–140
Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA (2003) The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Release 90(2):243–255
Honeywell-Nguyen PL, Gooris GS, Bouwstra JA (2004) Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 123(5):902–910
Jain S, Tiwary AK, Jain NK (2006) Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr Drug Deliv 3(2):157–166
Jung S, Otberg N, Thiede G, Richter H, Sterry W, Panzner S, Lademann J (2006) Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 126(8):1728–1732
Kirjavainen M, Urtti A, Jaaskelainen I, Suhonen TM, Paronen P, Valjakka-Koskela R, Kiesvaara J, Monkkonen J (1996) Interaction of liposomes with human skin in vitro–the influence of lipid composition and structure. Biochim Biophys Acta 1304(3):179–189
Kumar A, Pathak K, Bali V (2012) Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today 17(21–22):1233–1241
L’Oreal INV, Vanlerberghe G, Handjani-Vila RM (1975) Procédé de fabrication de dispersion aqueuses de spérules lipidiques et nouvelles compositions correspondantes. France Patent # 2315991
Liu X, Liu H, Zeng Z, Zhou W, Liu J, He Z (2011) Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect. Int J Nanomedicine 6:1391–1398
Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR (2012) Niosomes: novel sustained release nonionic stable vesicular systems – an overview. Adv Colloid Interface Sci 183–184:46–54
Manconi M, Sinico C, Caddeo C, Vila AO, Valenti D, Fadda AM (2011) Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 412(1–2):37–46
Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Lampis S, Monduzzi M, Fadda AM (2012) Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability. Eur J Pharm Biopharm 82:352–359
Mezei M, Gulasekharam V (1980) Liposomes–a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 26(18):1473–1477
Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK (2006) Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 24(22):4847–4855
Mishra D, Garg M, Dubey V, Jain S, Jain NK (2007) Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 96(1):145–155
Paul A, Cevc G, Bachhawat BK (1995) Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur J Immunol 25(12):3521–3524
Paul A, Cevc G, Bachhawat BK (1998) Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine 16(2–3):188–195
Puri R, Jain S (2012) Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Anticancer Drugs 23(9):923–934
Schatzlein A, Cevc G (1998) Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br J Dermatol 138(4):583–592
Sinico C, Fadda AM (2009) Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 6(8):813–825
Song YK, Kim CK (2006) Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27(2):271–280
Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S (2006) Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 323(1–2):1–10
Touitou E (1996) Compositions for applying active substances to or through the skin. US Patent 5,540,934
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65(3):403–418
Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F (2001) Intracellular delivery mediated by an ethosomal carrier. Biomaterials 22(22):3053–3059
Trotta M, Peira E, Debernardi F, Gallarate M (2002) Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241(2):319–327
Trotta M, Peira E, Carlotti ME, Gallarate M (2004) Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270(1–2):119–125
van den Bergh BA, Bouwstra JA, Junginger HE, Wertz PW (1999a) Elasticity of vesicles affects hairless mouse skin structure and permeability. J Control Release 62(3):367–379
van den Bergh BA, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA (1999b) Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim Biophys Acta 1461(1):155–173
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benson, H.A.E. (2016). Vesicles for Transdermal Delivery of Peptides and Proteins. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47862-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-662-47862-2_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47861-5
Online ISBN: 978-3-662-47862-2
eBook Packages: MedicineMedicine (R0)